Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / ordered9kclusters / clust_142.txt

Download this file

123 lines (122 with data), 8.3 kB 

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
Aspartate aminotransferase (AST) =< 3 x ULN

Aspartate aminotransferase (AST) =< 3.0 X ULN, within 14 days of registration

Aspartate aminotransferase (AST) and/or ALT ? 2.5 × ULN

Aspartate aminotransferase (AST) < 5 times ULN

Aspartate aminotransferase (AST [SGOT]) ?2.5 × the ULN;

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 2 x ULN OR if hepatic involvement by lymphoma: AST =< 5 x ULN

aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

Aspartate aminotransferase (AST) =< 1.5 x institutional ULN

Aspartate aminotransferase (AST) =< 3 X ULN

INCLUSION - TREATMENT: Aspartate aminotransferase (AST) ? 5x

Within 14 days of the first dose of study drug: Aspartate aminotransferase (AST) =< 3 x ULN

Aspartate aminotransferase (AST) level =< 2.5 × ULN.

Aspartate aminotransferase (AST) < 3 x ULN unless due to the underlying leukemia approved by the PI

Aspartate aminotransferase (AST) ? 3.0 x ULN (unless considered due to leukemic organ involvement)

Aspartate aminotransferase (AST) greater than 2.0 times the ULN in the absence of known hepatic metastases

Aspartate aminotransferase (AST) > 45 U/L

Aspartate aminotransferase (AST) =< 3 x ULN.

Aspartate aminotransferase (AST) level =< 2.5 x ULN

Serum aspartate aminotransferase (AST) ?3 × ULN (Grade ?1).

Aspartate aminotransferase (AST) < 3 x ULN unless considered due to leukemic involvement

Aspartate aminotransferase (AST) ? 1.5 x ULN

aspartate aminotransferase (AST) <= 3.0 x ULN*

Aspartate aminotransferase (AST) =< 2.5 x ULN

To be performed within 14 days prior to day 1 of protocol therapy: aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN.

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN within 14 days of study registration.

Aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN (=< 5 x ULN for subjects with documented metastatic disease to the liver).

Aspartate aminotransferase (AST) within 2.5 x ULN unless there are liver metastases in which case, AST within 5 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN.

Aspartate aminotransferase (AST) =< 2.0 x ULN

Aspartate aminotransferase (AST) within 2.5 x ULN unless there are liver metastases in which case, AST within 5 x ULN

Aspartate aminotransferase (AST) =< 5 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN

Obtained within 14 days of randomization: Aspartate aminotransferase (AST) =< 3 x ULN

aspartate aminotransferase (AST) ? 3.0 × ULN*

Aspartate aminotransferase (AST) =< 2.5 x ULN prior to biopsy

Aspartate transaminase (aspartate aminotransferase [AST]) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN (obtained within 28 days prior to first study treatment)\r\n* Subjects with documented liver metastases should have AST =< 5 x ULN

LYMPHODEPLETION: Aspartate aminotransferase (AST) =< 3.0 x ULN, obtained within 72 hrs prior to procurement

Aspartate aminotransferase (AST) and AST <3x institutional ULN within 7 days prior to starting the study drug.

Aspartate aminotransferase (AST) =< 1.5 x ULN for the laboratory

Aspartate aminotransferase (AST) < 3 x ULN

Aspartate aminotransferase (AST) =< 1.5 x ULN

Aspartate aminotransferase (AST) =< 2 x ULN for the laboratory

Aspartate transaminase (aspartate aminotransferase [AST]) > 3.0 x ULN

Aspartate aminotransferase (AST) =< 2.5 X ULN

Aspartate aminotransferase (AST) < 2.5 x ULN (3 x ULN for subjects on chronic anticonvulsive therapies known to increase transaminases).

PRIOR TO CELL PROCUREMENT: Aspartate aminotransferase (AST) ? 3 times ULN

Aspartate aminotransferase (AST) =< 3 x ULN for the laboratory, except in the presence of known hepatic metastasis, wherein the AST may be =< 5 x ULN

Aspartate aminotransferase =< 3 x ULN

Within 3 months of registration: Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 3 times the ULN

Within 14 days prior to study entry: Aspartate aminotransferase (AST) =< 3 x ULN

Any serum aspartate aminotransferase (AST) is allowed but serum AST =< 34 IU/L is strongly encouraged

Aspartate aminotransferase (AST) =< 2.5 x ULN for the laboratory

Aspartate aminotransferase (AST) =< 3.5 x ULN

TREATMENT: Aspartate aminotransferase (AST) < 5 × ULN

Aspartate aminotransferase (AST) =< 3 x ULN (must be within 7 days of MLA)

Aspartate aminotransferase (AST) =< 121 IU/L

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) > 3 x ULN

Aspartate aminotransferase (AST) < 5 x ULN

Aspartate aminotransferase (AST) < 3 times the ULN

Aspartate aminotransferase level (<=) 2.5* ULN, and

Aspartate aminotransferase (AST) within the reference range during screening evaluation

Aspartate aminotransferase (AST) > 5 x ULN

To be performed within 14 days prior to day 1 of protocol therapy: aspartate aminotransferase (AST) =< 3 x ULN\r\n* If hepatic involvement by lymphoma: AST =< 5 x ULN

Within 14 days prior to day 1 of protocol therapy unless otherwise stated: Aspartate aminotransferase (AST) =< 2 x ULN

At cycle 1 day 1 pre-dosing: Aspartate aminotransferase (AST) >= 2.5 x the ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN for the laboratory

Aspartate aminotransferase (AST) =< 3 x ULN

Aspartate aminotransferase (AST) =< 2 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN for the laboratory

Aspartate aminotransferase (AST) < 2.5 x ULN of the institutional normal reference range

Aspartate aminotransferase (AST) must be =< 1.5 x ULN for the lab

Aspartate transaminase (aspartate aminotransferase [AST]) =< 2.5 x ULN (=< 5 x ULN in patients with liver metastasis), obtained =< 21 days prior to registration

Aspartate aminotransferase (AST) ? 2.0 X ULN,

Aspartate aminotransferase (AST) ? 2 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN within 14 days prior to study registration

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase less than or equal to 3 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN

Aspartate aminotransferase (AST) < 5 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN

Aspartate aminotransferase (AST) =< 1.5 X ULN

and aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

Aspartate aminotransferase (AST) ? 1.5 x ULN unless there is hepatic involvement, then 3 x ULN

Aspartate aminotransferase (AST) =< 5 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 3 X ULN

Aspartate aminotransferase (AST) =< 1.5 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN

Aspartate aminotransferase (AST) =< 3 x ULN

Aspartate aminotransferase (AST) =< 2.5 x the ULN for age (in the absence of hepatic involvement of tumor)

Aspartate aminotransferase (AST) ? 2.5 × ULN or ? 5 × ULN for subjects with known hepatic metastases

Aspartate aminotransferase > 100 IU/L

Aspartate aminotransferase (AST) ?3 × ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) =< 1.5 X ULN

Aspartate aminotransferase (AST) =< 2.5 x the ULN (in the absence of hepatic involvement of tumor)

Aspartate aminotransferase (AST) =< 3 times ULN

Aspartate aminotransferase (AST) and ALT < 3.0 × ULN

Aspartate aminotransferase (AST) =< 3 times ULN

Aspartate aminotransferase (AST) =< 2.5 x ULN

Aspartate aminotransferase (AST) < 5 x ULN

Aspartate aminotransferase (AST) < 5.0 x ULN

Aspartate aminotransferase (AST) =< 2 x institutional ULN

Aspartate aminotransferase level (AST) =< 3 x ULN, within 30 days prior to enrollment

Obtained within 28 days prior to registration: Aspartate aminotransferase (AST) =< 2.5 x ULN (subjects with documented liver metastases should have AST =< 5 x ULN)

Aspartate aminotransferase (AST) < 3 × ULN unless hepatic metastases are present, then < 5 × ULN

Aspartate aminotransferase (AST) < 5 X institutional ULN

Aspartate aminotransferase (AST) =< 1.5 x ULN

Aspartate aminotransferase (AST) > 3 x ULN

Aspartate aminotransferase =< 45 IU/dL